Med­ical tech­nol­ogy com­pany Pre­ci­Point today announced the launch of its iO:M8 live dig­i­tal micro­scope. The micro­scope is an inno­v­a­tive solu­tion for dig­i­tiz­ing intra­op­er­a­tive exam­i­na­tions in can­cer surgery. The device recently received cer­ti­fi­ca­tion as a CE-IVD prod­uct. This first prod­uct cer­ti­fi­ca­tion under the new IVDR reg­u­la­tion is an impor­tant mile­stone in PreciPoint’s cor­po­rate development.

Pre­ci­Point is a young med­ical tech­nol­ogy com­pany pro­duc­ing solu­tions for the dig­i­ti­za­tion of microscopy and lab­o­ra­tory processes for appli­ca­tions in med­i­cine, research and edu­ca­tion. In the devel­op­ment of its prod­ucts, the com­pany already col­lab­o­rates with many renowned pathol­o­gists in Ger­many. On the one hand, many gov­ern­ment-funded projects are advanc­ing promis­ing approaches in the ther­apy of numer­ous can­cers, and on the other hand, the com­pany is devel­op­ing the devices that make these research results vis­i­ble and sim­plify lab­o­ra­tory processes. “Where you live should not deter­mine whether you live. The pos­si­bil­i­ties of dig­i­tal pathol­ogy enable bet­ter patient care, and our prod­ucts facil­i­tate access to dig­i­tal pathol­ogy,” explained Dominik Ger­ber, CEO of Pre­ci­Point GmbH.

The company’s lat­est devel­op­ment, the iO:M8, offers a dis­tinc­tive solu­tion for dig­i­tiz­ing intra­op­er­a­tive can­cer exams. Dur­ing these exam­i­na­tions, pathol­o­gists deter­mine dur­ing surgery whether tumor tis­sue has been com­pletely removed from the patient’s body and whether the mar­gins of the oper­ated site are free of can­cer cells. Tra­di­tion­ally, these exam­i­na­tions are per­formed at a spe­cific loca­tion and time using tra­di­tional light microscopy. How­ever, the iO:M8 was devel­oped specif­i­cally for this appli­ca­tion and allows tis­sue removed dur­ing surgery to be cryo­sta­t­i­cally frozen in a frozen sec­tion­ing process, sec­tioned and mounted on glass slides. The iO:M8 can accom­mo­date up to four slides simul­ta­ne­ously. It pro­vides high-res­o­lu­tion images of the sam­ples in real time while being easy to use. “In view of the increas­ing short­age of pathol­o­gists cou­pled with the ris­ing num­ber of can­cer cases in Ger­many, Europe and world­wide, solu­tions like PreciPoint´s are indis­pens­able,” com­mented Nico­las Weiss, who heads the com­pany together with Dominik Ger­ber. The iO:M8 is a med­ical device used in med­ical ther­apy. There­fore, the basic prin­ci­ples of safety and per­for­mance must be demon­strated for use. Only the CE-IVD mark­ing pro­vides this security.

“We are pleased that our iO:M8 live micro­scope has passed all the required tests and reg­u­la­tions. This ensures that it meets the high­est qual­ity and reli­a­bil­ity stan­dards as an IVD med­ical device. This micro­scope will help drive dig­i­ti­za­tion in health­care and we are excited about the impact it will have in the med­ical com­mu­nity,” said Ger­ber. Nico­las Weiss added, “CE-IVD cer­ti­fi­ca­tion is a tes­ta­ment to the hard work and ded­i­ca­tion of our team, which has invested count­less months to ensure this micro­scope meets the high­est per­for­mance and safety stan­dards. With this cer­ti­fi­ca­tion, our cus­tomers can be assured that they are get­ting a safe, reli­able and effec­tive tool for their diag­nos­tic tasks. We are very excited to bring this cut­ting-edge tech­nol­ogy to mar­ket and con­tribute to the advance­ment of med­ical tech­nol­ogy and healthcare.”

About Pre­ci­Point

bm|t Investee Part­ner Pre­ci­Point, is a cer­ti­fied med­ical device com­pany (ISO 13485) that devel­ops cus­tomized solu­tions to bridge the gap between dig­i­tal work­flows and pathol­o­gists. The com­pany devel­ops and dis­trib­utes fully motor­ized light micro­scopes and scan­ners world­wide with a pas­sion for bring­ing the dig­i­ti­za­tion of microscopy to pathol­ogy. PreciPoint’s prod­ucts include the M8 micro­scope and scan­ner, the O8 oil micro­scope and scan­ner, and the FRITZ scan­ner. These prod­ucts pro­duce high-res­o­lu­tion dig­i­tal images of spec­i­mens for review and inter­pre­ta­tion by pro­fes­sion­als. In addi­tion to hard­ware prod­ucts, the com­pany also offers multi-pur­pose soft­ware appli­ca­tions and ser­vices, includ­ing Micro­P­oint, View­Point, Pre­ci­Cloud, Scan­Point, and Con­vert­Point, as well as other cus­tomized solu­tions for pathol­o­gists and med­ical pro­fes­sion­als. The com­pany has received numer­ous awards and recog­ni­tions, includ­ing Top Employer 2023 and Top100 Inno­va­tor 2022, and Pre­ci­Point has also been named a Top Employer for Health­care Startups.

www.precipoint.com